Skip to content
Disclosery

Maple-Brown Abbott Ltd: LNG position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of Maple-Brown Abbott Ltd on LNG, newest first. How the timeline and the estimate are built.

Maple-Brown Abbott Ltd held 250,592 LNG shares at 2025-03-31 per its 13F-HR filed 2025-05-13.

the latest 13F is the newest step

  1. period ended2025-03-31
    13F 250,592 shares
    Change vs previous 13F +52,322 shares

    3.95% of the 13F portfolio, value $57,991,642.

    13F-HR 0001681596-25-000005 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  2. period ended2024-12-31
    13F 198,270 shares
    Change vs previous 13F -79,240 shares

    5.2% of the 13F portfolio, value $42,602,276.

    13F-HR 0001681596-25-000002 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2024-09-30
    13F 277,510 shares
    Change vs previous 13F -42,010 shares

    4.95% of the 13F portfolio, value $49,907,398.

    13F-HR 0001681596-24-000016 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-06-30
    13F 319,520 shares
    Change vs previous 13F +18,420 shares

    5.89% of the 13F portfolio, value $55,861,682.

    13F-HR 0001681596-24-000006 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-03-31
    13F/A 301,100 shares
    Change vs previous 13F +22,180 shares

    4.97% of the 13F portfolio, value $48,561,408.

    13F-HR/A 0001681596-24-000012 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  6. period ended2023-12-31
    13F/A 278,920 shares
    Change vs previous 13F -18,690 shares

    4.85% of the 13F portfolio, value $47,594,909.

    13F-HR/A 0001681596-24-000010 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  7. period ended2023-09-30
    13F/A 297,610 shares
    Change vs previous 13F -53,930 shares

    5.67% of the 13F portfolio, value $49,431,532.

    13F-HR/A 0001681596-24-000009 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  8. period ended2023-06-30
    13F/A 351,540 shares
    Change vs previous 13F not available

    5.96% of the 13F portfolio, value $53,637,973.

    13F-HR/A 0001681596-24-000008 filed by Maple-Brown Abbott Ltd
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).